Sirolimus 0.002 MG/MG Topical Gel [Hyftor] — RxCUI 2596869
RxNorm drug concept · Semantic branded drug
RxCUI 2596869
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2596869
Official nameSirolimus 0.002 MG/MG Topical Gel [Hyftor]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHyftor 0.2 % Topical Gel; Hyftor 0.002 MG/MG Topical Gel
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)2,154 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sirolimus: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sirolimus comes in a few different forms, and each one has its own approved use. The oral tablets and liquid are mainly used to prevent kidney transplant rejection and to treat a r...
- What exactly is sirolimus being used for — I've seen it listed for so many different things?
- Yes, it matters — but not in the way you might think. You don't have to eat with it, but you do need to be consistent. Food, especially a high-fat meal, can increase how much sirol...
- Does it matter if I take my oral sirolimus with food or without?
🕸️ Concept Web — How Sirolimus 0.002 MG/MG Topical Gel [Hyftor] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sirolimus 0.002 MG/MG Topical Gel [Hyftor]
RxCUI 2596869 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sirolimus
35302IN
-
Sirolimus
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Hyftor
2596865BN
-
Hyftor
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sirolimus Topical Gel
2596863SCDF -
Sirolimus Topical Product
2596862SCDG -
Sirolimus Topical Gel [Hyftor]
2596868SBDF -
Hyftor Topical Product
2596867SBDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Sirolimus Topical Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sirolimus 0.002 MG/MG Topical Gel
2596864SCD -
Sirolimus 0.002 MG/MG
2596861SCDC -
Sirolimus 0.002 MG/MG [Hyftor]
2596866SBDC
-
Sirolimus 0.002 MG/MG Topical Gel
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sirolimus 0.002 MG/MG Topical Gel
SCD · 2596864 -
Sirolimus 0.002 MG/MG
SCDC · 2596861 -
Sirolimus Topical Gel
SCDF · 2596863 -
Sirolimus Topical Product
SCDG · 2596862
Brand-Name Concepts
-
Sirolimus 0.002 MG/MG [Hyftor]
SBDC · 2596866 -
Sirolimus Topical Gel [Hyftor]
SBDF · 2596868 -
Hyftor Topical Product
SBDG · 2596867 -
Hyftor
BN · 2596865
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2596869 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 73683-0101-10 | 1 TUBE in 1 CARTON (73683-101-10) / 10 g in 1 TUBE | HYFTOR | Nobelpharma America, LLC | 2022-03-23 |
Observed labelers:
Nobelpharma America, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.